Amoeba SA Financials
| ALMIB Stock | EUR 0.81 0.02 2.41% |
Amoeba |
Understanding current and past Amoeba SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amoeba SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Amoeba SA's assets may result in an increase in income on the income statement.
Amoeba SA Stock Summary
Amoeba SA competes with Gaussin, Blockchain Group, Gensight Biologics, and Europlasma. Amoba S.A. develops and sells biocidal and fungicide products. The company was founded in 2010 and is headquartered in Chassieu, France. AMOEBA is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011051598 |
| Business Address | 38 Avenue de |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| Benchmark | Dow Jones Industrial |
| Website | amoeba-nature.com |
| Phone | 33 4 26 69 16 00 |
| Currency | EUR - Euro |
You should never invest in Amoeba SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amoeba Stock, because this is throwing your money away. Analyzing the key information contained in Amoeba SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amoeba SA Key Financial Ratios
Amoeba SA's financial ratios allow both analysts and investors to convert raw data from Amoeba SA's financial statements into concise, actionable information that can be used to evaluate the performance of Amoeba SA over time and compare it to other companies across industries.| Return On Equity | -3.49 | |||
| Return On Asset | -0.29 | |||
| Number Of Employees | 18 | |||
| Beta | 0.22 | |||
| Z Score | 76.2 |
Amoeba Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amoeba SA's current stock value. Our valuation model uses many indicators to compare Amoeba SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amoeba SA competition to find correlations between indicators driving Amoeba SA's intrinsic value. More Info.Amoeba SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amoeba SA's earnings, one of the primary drivers of an investment's value.Amoeba SA Systematic Risk
Amoeba SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amoeba SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Amoeba SA correlated with the market. If Beta is less than 0 Amoeba SA generally moves in the opposite direction as compared to the market. If Amoeba SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amoeba SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amoeba SA is generally in the same direction as the market. If Beta > 1 Amoeba SA moves generally in the same direction as, but more than the movement of the benchmark.
Amoeba SA November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amoeba SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amoeba SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amoeba SA based on widely used predictive technical indicators. In general, we focus on analyzing Amoeba Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amoeba SA's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.75 | |||
| Information Ratio | 0.1211 | |||
| Maximum Drawdown | 12.75 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 7.14 |
Additional Tools for Amoeba Stock Analysis
When running Amoeba SA's price analysis, check to measure Amoeba SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amoeba SA is operating at the current time. Most of Amoeba SA's value examination focuses on studying past and present price action to predict the probability of Amoeba SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amoeba SA's price. Additionally, you may evaluate how the addition of Amoeba SA to your portfolios can decrease your overall portfolio volatility.